Indications and uses
Cures most athlete's foot, jock itch & ringworm Relieves itching, burning, cracking, and discomfort which accompany these conditions
Cures most athlete's foot, jock itch & ringworm Relieves itching, burning, cracking, and discomfort which accompany these conditions
Clean affected area and dry thoroughly. Apply a thin layer over affected area twice daily (morning & night) or as directed by a doctor. For athlete's foot pay special attention to the space between the toes. Wear well fitting, ventilated shoes and change shoes & socks at least once a day. For athlete's foot and ringworm, use daily for 4 weeks For jock itch use daily for 2 weeks. Supervise Children in use of this p...
Store at 59° - 86° F
Drug Facts
| Active Ingredients | Purpose |
|---|---|
| Undecylenic Acid 2% | Antifungal |
| Zinc Undecylenate 20% | Antifungal |
KEEP OUT OF REACH OF CHILDREN.
In case of accidental ingestion seek professional assistance or contact a poison control center right away.
Store at 59° - 86° F
talc
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1491970 | SANAFITIL 2 % / 20 % Topical Powder | PSN | 1 |
| 313817 | undecylenic acid 2 % / zinc undecylenate 20 % Topical Powder | PSN | 1 |
| 1491970 | undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG Topical Powder [Sanafitil Powder] | SBD | 1 |
| 313817 | undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG Topical Powder | SCD | 1 |
| 1491970 | Sanafitil Powder (undecylenic acid 2 % / zinc undecylenate 20 % ) Topical Powder | SY | 1 |
| 313817 | undecylenic acid 2 % / zinc undecylenate 20 % Topical Powder | SY | 1 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61357-152-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3b5e-60a7-e053-dbdaa90a05bd | Sanafitil ® Talco |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61357-152-01 | Sanafitil Talco | 1 in 1 CARTON | POWDER | 1 | 1 | |
| 61357-152-01 | Sanafitil Talco | 57 g in 1 BOTTLE | POWDER | 57 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| UNDECYLENIC ACID | ACTIVE INGREDIENT | K3D86KJ24N | 1 | |
| ZINC UNDECYLENATE | ACTIVE INGREDIENT | 388VZ25DUR | 1 | |
| UNDECYLENIC ACID | ACTIVE MOIETY | K3D86KJ24N | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61357-152 | 61357-152-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| UNDECYLENIC ACID | K3D86KJ24N | ACTIB |
| ZINC UNDECYLENATE | 388VZ25DUR | ACTIB |
| TALC | 7SEV7J4R1U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| TALC | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4b57c6de-c555-41a0-8789-4cc84a62f16b | 105c961c-81ee-4b44-b39e-1501132114f0 | 2014-03-12 | Warnings | 4b57c6de-c555-41a0-8789-4cc84a62f16b 105c961c-81ee-4b44-b39e-1501132114f0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.